Dual ACE and Neutral Endopeptidase Inhibitors
Author:
- 1 January 2003
- journal article
- research article
- Published by Springer Nature in Drugs
- Vol. 63 (20) , 2185-2202
Abstract
Elevated blood pressure is a risk factor for a variety of cardiovascular disorders, including coronary heart disease, peripheral vascular disease, cardiac failure and cerebrovascular disease. The...Keywords
This publication has 85 references indexed in Scilit:
- Omapatrilat- the story of Overture and OctaveInternational Journal of Cardiology, 2002
- Omapatrilat Reduces Pulse Pressure and Proximal Aortic Stiffness in Patients With Systolic HypertensionCirculation, 2002
- Omapatrilat Versus LisinoprilHypertension, 2001
- Effects of Age and Gender on the Pharmacodynamics of Omapatrilat in Healthy VolunteersThe American Journal of Geriatric Cardiology, 2001
- Effects of the dual metallopeptidase inhibitor, MDL 100,240, on regional haemodynamic responses to vasoactive peptides in conscious ratsBritish Journal of Pharmacology, 1997
- The integrated effects of angiotensin IIThe American Journal of Cardiology, 1997
- Cardiorenal Consequences of Dual Angiotensin Converting Enzyme and Neutral Endopeptidase 24.11 Inhibition in Transgenic Rats with an Extra Renin Gene.Hypertension Research, 1996
- Dual Inhibition of Angiotensin-Converting Enzyme and Neutral Endopeptidase in Rats with HypertensionJournal of Cardiovascular Pharmacology, 1995
- The Clinical Potential of Renin Inhibitors and Angiotensin AntagonistsDrugs, 1994
- Perspectives on systolic hypertension. The Framingham study.Circulation, 1980